Get the Stockscreener App
1.67
0.60%
0.01
After Hours:
1.64
-0.03
-1.80%
Q 32 Bio Inc stock is traded at $1.67, with a volume of 73,157.
It is up +0.60% in the last 24 hours and down -15.66% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
See More
Previous Close:
$1.66
Open:
$1.75
24h Volume:
73,157
Relative Volume:
0.06
Market Cap:
$20.37M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.34%
1M Performance:
-15.66%
6M Performance:
-25.61%
1Y Performance:
-96.35%
1-Day Range:
$1.63
$1.81
1-Week Range:
$1.62
$1.82
52-Week Range:
$1.345
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Compare QTTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.67 | 20.25M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-11-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-11-24 | Downgrade | Guggenheim | Buy → Neutral |
| Dec-11-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | Raymond James | Strong Buy |
| Sep-11-24 | Initiated | Wells Fargo | Overweight |
| Jun-17-24 | Initiated | Guggenheim | Buy |
| May-21-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Oppenheimer | Outperform |
| Apr-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-28-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-22-22 | Reiterated | BTIG Research | Neutral |
| Feb-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-22-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-21 | Initiated | Stifel | Hold |
| Dec-14-20 | Resumed | H.C. Wainwright | Buy |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-16-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-24-20 | Initiated | Chardan Capital Markets | Buy |
| Nov-01-19 | Initiated | Oppenheimer | Perform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Apr-12-19 | Initiated | Evercore ISI | Outperform |
View All
Q 32 Bio Inc Stock (QTTB) Latest News
Is it too late to sell Q32 Bio Inc.July 2025 Recap & Free Fast Gain Swing Trade Alerts - Newser
What moving averages say about Q32 Bio Inc.Long Setup & Daily Volume Surge Trade Alerts - Newser
Developing predictive dashboards with Q32 Bio Inc. dataWeekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
Buyout Rumor: How liquid is Q32 Bio Inc. stockPortfolio Return Summary & Step-by-Step Trade Execution Guides - خودرو بانک
Can Q32 Bio Inc. lead its sector in growthTrade Risk Assessment & Capital Efficiency Focused Strategies - خودرو بانک
Using RSI to spot recovery in Q32 Bio Inc.July 2025 Patterns & Fast Exit and Entry Strategy Plans - Newser
Should I invest in Q32 Bio Inc. before earningsCPI Data & Verified Entry Point Detection - خودرو بانک
Analyzing Q32 Bio Inc. with risk reward ratio chartsQuarterly Trade Report & Precise Buy Zone Tips - Newser
Can trapped investors hope for a rebound in Q32 Bio Inc.Market Risk Summary & Fast Moving Market Watchlists - Newser
Will Q32 Bio Inc. rebound enough to break even2025 Technical Overview & Stock Timing and Entry Methods - Newser
Is Q32 Bio Inc. stock a top performer YTDJuly 2025 EndofMonth & Weekly Top Stock Performers List - خودرو بانک
Should you wait for a breakout in Q32 Bio Inc.July 2025 Market Mood & High Return Trade Guides - Newser
Real time social sentiment graph for Q32 Bio Inc.Market Sentiment Review & Technical Entry and Exit Alerts - Newser
Has Q32 Bio Inc. formed a bullish divergenceForecast Cut & High Win Rate Trade Alerts - Newser
Q32 Bio Inc. stock outlook for YEARBuy Signal & Technical Pattern Based Signals - Newser
How to interpret RSI for Q32 Bio Inc. stockMarket Weekly Review & AI Powered Market Entry Ideas - Newser
How much upside does Q32 Bio Inc. haveJuly 2025 Spike Watch & Safe Capital Preservation Plans - خودرو بانک
Order flow analysis tools used on Q32 Bio Inc.Trade Risk Assessment & Daily Chart Pattern Signals - Newser
Can Q32 Bio Inc. keep up with sector leadersQuarterly Growth Report & Fast Moving Stock Watchlists - خودرو بانک
Applying big data sentiment scoring on Q32 Bio Inc.2025 Sector Review & Short-Term High Return Strategies - Newser
Can Q32 Bio Inc. be recession proofJuly 2025 Setups & High Accuracy Swing Trade Signals - خودرو بانک
Q32 Bio Inc. stock retracement – recovery analysisPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - Newser
Q32 Bio Inc. Volume Confirms Breakout — Analysts Bullish getLinesFromResByArray error: size == 0 - 강소기업뉴스
Should you hold or exit Q32 Bio Inc. nowStock Surge & Safe Swing Trade Setups - Newser
Chart based analysis of Q32 Bio Inc. trendsWeekly Profit Recap & Safe Entry Trade Reports - Newser
Sector ETF performance correlation with Q32 Bio Inc.CPI Data & Expert Approved Momentum Ideas - Newser
Is Q32 Bio Inc. stock bottoming out2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser
Published on: 2025-08-30 19:56:22 - Newser
Using data tools to time your Q32 Bio Inc. exitJuly 2025 Catalysts & Entry and Exit Point Strategies - Newser
Real time scanner hits for Q32 Bio Inc. explained2025 Market WrapUp & Accurate Buy Signal Alerts - Newser
Momentum Indicator Shows Bearish Divergence in Q32 Bio Inc.Market Growth Review & Growth Focused Entry Point Reports - beatles.ru
Using fundamentals and technicals on Q32 Bio Inc.July 2025 Reactions & Daily Profit Focused Screening - Newser
Q32 Bio Inc. Stock (QTTB) Opinions on Wells Fargo Healthcare Conference Participation - Quiver Quantitative
Q 32 Bio Inc Stock (QTTB) Financials Data
There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):